Eli Lilly & Company
Over
Lilly is a global healthcare leader that unites caring with discovery to create medicines that make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.
To learn more about Lilly, please visit us at www.lilly.co.uk.
Adres
Lilly House
Basing View
Basingstoke
Hampshire
United Kingdom
RG21 4FA
Contact details
Medische Informatietelefoon
+44-(0)1256-315000
Openingstijden
Mon-Fri 10am - 4pm (excl. bank holidays)
Medische informatie website
https://www.lillymedical.co.uk/en-gb
Medische informatie E-mail
ukmedinfo@lilly.com
Live chat
Bijwerkingen en productklachten
Please do not use this website to report side effects or product complaints.
If you experience side effects, talk to your doctor or other healthcare professional. This includes any possible side effects not listed in the package leaflet. To report a side effect or product complaint with a Lilly product please call Lilly UK on 01256 315000. Additionally, reporting forms and further information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple
Meld een ongewenst voorval Telefoon
44-(0)1256-315000
Healthcare Professionals can submit medical enquiry URL:
https://www.lillymedical.eu/en-gb/submitquestion
Company website:
https://www.lilly.co.uk
Lilly producten
Geneesmiddelen gemarkeerd met een ▼ zijn onderworpen aan aanvullende monitoring. Dit maakt een snelle identificatie van nieuwe veiligheidsinformatie mogelijk. U kunt helpen door bijwerkingen te melden die u kunt krijgen.
Abasaglar®
(Insulin glargine)
Adcirca®
(tadalafil)
Alimta®
(pemetrexed)
Cialis®
(tadalafil)
Cymbalta®
(duloxetine)
Cyramza®
(ramucirumab)
Emgality®
(galcanezumab)
Forsteo®
(teriparatide)
Humalog®
(human insulin analogue)
Humulin®
(human insulin)
Lyumjev® ▼
(insulin lispro)
Mounjaro® ▼
(tirzepatide)
Olumiant®
(baricitinib)
Omvoh® ▼
(mirikizumab)
Retsevmo® ▼
(selpercatinib)
Strattera®
(atomoxetine)
Taltz®
(ixekizumab)
Trulicity®
(dulaglutide)
Verzenios®
(abemaciclib)
Yentreve®
(duloxetine)
